Radioligand Therapy with 177Lu-PSMA-617 of metastatic prostate cancer has already been arrived in clinical use
Dear Editor.
Source: Nuclear Medicine and Biology - Category: Nuclear Medicine Authors: Hojjat Ahmadzadehfar, Markus Essler, Michael Sch äfers, Kambiz Rahbar Source Type: research